As the year ends, The 19th takes a look at how the conservative policy wishlist for President Donald Trump’s second term ...
Amgen Inc. raises 2025 revenue guidance on strong Repatha and Imdelltra sales and dividend hike. Click for this AMGN update.
Billions of prescriptions for generic drugs are filled in the U.S. annually. The FDA tests only a few dozen of them every ...
As of February 2025, the semaglutide injection (Ozempic, Wegovy) shortage was resolved. As a result, compounded semaglutide ...
The technology landscape is approaching a fundamental transformation. As we stand at the threshold of 2026, five key trends ...
They say laughter is the best medicine. Michael Miller, a cardiologist and medical professor at the University of Pennsylvania, says they’re right. Laughter is an obvious stress reliever. But ...
Needle-Free Growth Hormone Support via Telehealth - Platform Analysis Compares Compounded Prescription Tablets vs. Injectable ...
AZ Animals on MSN
I Used to Enjoy Fireworks Until I Saw How They Impacted My Dog
My love of fireworks came to an abrupt end when my dog became terrified of them. This is what my research revealed.
RejuvaCare FootRenew reports 1,900+ customer reviews as Triple Method heat-massage-compression devices gain market share ...
Conclusions Cognitive impairment is associated with increased risks of cardiovascular death and composite cardiovascular outcomes. Uncontrolled lifestyle, cardiometabolic and psychological risk ...
Combination therapy with a nonsteroidal mineralocorticoid receptor antagonist and an SGLT2 inhibitor reduced albuminuria more ...
BioMarin Pharmaceutical’s strong rare disease drug portfolio and Amicus acquisition drive a ‘Buy’ rating. Click here to read my latest analysis of BMRN stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback